UNSPSC 51432400: Antihypertensive imino acids

Antihypertensive drugs made from secondary amino acids and carboxylic acids.

UNSPSC 51432400 Antihypertensive imino acids is a Class code under which state and local governments procure emergency-care and pharmacy-program medications, primarily antihypertensive agents and related injectable pharmaceuticals for emergency medical services and hospital formularies. Recent solicitations show fire-rescue departments, state health agencies, and multi-state cooperative purchasing alliances buying specific branded and generic formulations—Labetalol, Diltiazem, Epinephrine, and Adenosine among them—in vial and injection configurations with strict expiration-dating requirements, OSHA compliance, and direct-distribution logistics. Issuing bodies include municipal fire-rescue purchasing (City of Tampa), state health departments (Texas Health and Human Services Commission), and cooperative purchasing vehicles serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). The market mixes competitive sealed-bid procurements for immediate operational supply with longer-term RFP vehicles for statewide or multi-state formulary frameworks, reflecting both ad-hoc emergency-care replenishment and strategic pharmacy-benefit program design.

Activity spans Florida, Texas, and Minnesota within the recent record. The City of Tampa issued IFB No. 26P00188 on April 24, 2026 (response due April 8, 2026) for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with a nine-month minimum shelf life and $40,000 estimated contract value, awarded to the lowest responsive bidder with a one-year term and two renewal options, including a 5 percent Small Local Business Enterprise (SLBE) bid discount. The Texas Health and Human Services Commission posted an RFI (No. HHS0017013, April 3, 2026 response deadline) to explore vendor capacity for direct-to-manufacturer pharmacy benefit contracting outside traditional PBM and wholesaler channels. MMCAP, administered by the Minnesota Department of Administration, issued an RFP (response due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, requiring mandatory wholesaler distribution through AmerisourceBergen, Cardinal Health, or Morris & Dickson, two-year contract terms, and FDA/cGMP compliance with at least one-year expiration dating and six-month minimum shelf life.